527 related articles for article (PubMed ID: 27011184)
1. MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer.
Bertoli G; Cava C; Castiglioni I
Int J Mol Sci; 2016 Mar; 17(3):421. PubMed ID: 27011184
[TBL] [Abstract][Full Text] [Related]
2. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in prostate cancer: Functional role as biomarkers.
Kanwal R; Plaga AR; Liu X; Shukla GC; Gupta S
Cancer Lett; 2017 Oct; 407():9-20. PubMed ID: 28823964
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
Zhang YC; Xu Z; Zhang TF; Wang YL
World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
[TBL] [Abstract][Full Text] [Related]
7. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
Sharma N; Baruah MM
Clin Transl Oncol; 2019 Feb; 21(2):126-144. PubMed ID: 29951892
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer.
Aghdam AM; Amiri A; Salarinia R; Masoudifar A; Ghasemi F; Mirzaei H
Crit Rev Eukaryot Gene Expr; 2019; 29(2):127-139. PubMed ID: 31679268
[TBL] [Abstract][Full Text] [Related]
9. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
Bertoli G; Cava C; Castiglioni I
Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
[TBL] [Abstract][Full Text] [Related]
10. miRNAs as biomarkers in prostate cancer.
Casanova-Salas I; Rubio-Briones J; Fernández-Serra A; López-Guerrero JA
Clin Transl Oncol; 2012 Nov; 14(11):803-11. PubMed ID: 22855165
[TBL] [Abstract][Full Text] [Related]
11. miRNAs as novel biomarkers in the management of prostate cancer.
Filella X; Foj L
Clin Chem Lab Med; 2017 May; 55(5):715-736. PubMed ID: 26751899
[TBL] [Abstract][Full Text] [Related]
12. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.
Gordanpour A; Nam RK; Sugar L; Seth A
Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer.
Azani A; Omran SP; Ghasrsaz H; Idani A; Eliaderani MK; Peirovi N; Dokhani N; Lotfalizadeh MH; Rezaei MM; Ghahfarokhi MS; KarkonShayan S; Hanjani PN; Kardaan Z; Navashenagh JG; Yousefi M; Abdolahi M; Salmaninejad A
Pathol Res Pract; 2023 Aug; 248():154618. PubMed ID: 37331185
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as potential new biomarkers for prostate cancer.
Sita-Lumsden A; Dart DA; Waxman J; Bevan CL
Br J Cancer; 2013 May; 108(10):1925-30. PubMed ID: 23632485
[TBL] [Abstract][Full Text] [Related]
16. Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer.
Coradduzza D; Cruciani S; Arru C; Garroni G; Pashchenko A; Jedea M; Zappavigna S; Caraglia M; Amler E; Carru C; Maioli M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163550
[TBL] [Abstract][Full Text] [Related]
17. Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.
Selth LA; Townley S; Gillis JL; Ochnik AM; Murti K; Macfarlane RJ; Chi KN; Marshall VR; Tilley WD; Butler LM
Int J Cancer; 2012 Aug; 131(3):652-61. PubMed ID: 22052531
[TBL] [Abstract][Full Text] [Related]
18. Investigating differential miRNA expression profiling using serum and urine specimens for detecting potential biomarkers for early prostate cancer diagnosis.
Hasanoğlu S; Göncü B; Yücesan E; Atasoy S; Kayalı Y; Özten Kandaş N
Turk J Med Sci; 2021 Aug; 51(4):1764-1774. PubMed ID: 33550766
[TBL] [Abstract][Full Text] [Related]
19. Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.
Gu Y; Lei D; Qin X; Chen P; Zou YM; Hu Y
PLoS One; 2015; 10(10):e0140862. PubMed ID: 26484677
[TBL] [Abstract][Full Text] [Related]
20. A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer.
Farran B; Dyson G; Craig D; Dombkowski A; Beebe-Dimmer JL; Powell IJ; Podgorski I; Heilbrun L; Bolton S; Bock CH
Carcinogenesis; 2018 Apr; 39(4):556-561. PubMed ID: 29471417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
